Alumbre, Mary Crissanine .

HRN: 22-66-53  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2023
CEFUROXIME 1.5GM (VIAL)
06/19/2023
06/19/2023
IV
1.5gm
LD
Primary CS
Waiting Final Action 
06/19/2023
CEFUROXIME 1.5GM (VIAL)
06/19/2023
06/26/2023
IV
1.5 Grams
Q8
SP 1LTCS
Waiting Final Action 
06/20/2023
CEFUROXIME 500MG (TAB)
06/20/2023
06/27/2023
ORAL
500mg
BID
SP PRIMARY LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: